Methods and compositions for regulation of cd28 expression

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/70 (2006.01) A61K 31/711 (2006.01) A61K 35/12 (2006.01) A61K 48/00 (2006.01) A61P 37/02 (2006.01) C07H 21/00 (2006.01) C12N 5/08 (2006.01) C12N 15/09 (2006.01)

Patent

CA 2211621

Oligomers are provided which are capable of reducing CD28 gene in a T cell. In addition to specific sequences, the invention includes a class of oligomers having at least two sequences of GGGG separated by 3 to 5 bases. Targets include CD28 gene, 5' untranslated regions and initiation codon, and their respective transcripts. Methods include use of the oligomers to moderate the pathogenic effects on the immune system in immune system-mediated diseases including graft versus host disease, septic shock syndrome, viral diseases, psoriasis, Type I (insulin-dependent) diabetes mellitus, thyroiditis, sarcoidosis, multiple sclerosis, autoimmune uveitis, rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease.

L'invention concerne des oligomères capables de réduire l'expression du gène CD28 dans un lymphocyte T. Outre des séquences spécifiques, l'invention concerne une classe d'oligomères comprenant au moins deux séquences de GGGG séparées par 3 à 5 bases. Les cibles sont, entre autres, le gène CD28, les régions 5' non traduites et le codon d'initiation et leurs produits de transcription respectifs. Les méthodes englobent l'utilisation d'oligomères pour modérer les effets pathogènes sur le système immunitaire dans des maladies induites par le système immunitaire, dont la réaction du greffon contre l'hôte, le choc septique, les maladies virales, le psoriasis, le diabète sucré (insulino-dépendant) du Type I, la thyroïdite, la sarcoïdose, la sclérose en plaques, l'uvïte auto-immune, la polyarthrite rhumatoïde, le lupus érythémateux aigu dissimulé et l'affection abdominale inflammatoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for regulation of cd28 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for regulation of cd28 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for regulation of cd28 expression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1358234

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.